Filing Details
- Accession Number:
- 0001127602-19-019895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-24 16:25:34
- Reporting Period:
- 2019-05-22
- Accepted Time:
- 2019-05-24 16:25:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674993 | Simon, Christopher | 400 Wood Road Braintree MA 02184 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-22 | 53,654 | $0.00 | 274,645 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-05-23 | 24,412 | $99.39 | 250,233 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares earned from performance share unit awards granted to the reporting person on June 29, 2016 and July 26, 2017 with performance periods ending on March 30, 2019, based on achievement of 80.05% and 144.31% of their respective internal financial and performance metric targets, as certified by the Compensation Committee of the Board of Directors effective May 22, 2019.
- This number includes unvested restricted stock units previously reported.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the performance share units reported above. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.